Dormant
CCXI · Churchill Capital Corp XI
Last analysed ·
Resolved Graded and closed 2026-09-18 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.
Current thesis
De-SPAC humanoid pure-play still bleeding premium: $17.07 (2026-08-14) → $14.57 (2026-08-21) → $13.40 (2026-09-04), RSI(14) down to 25.9. The only company-dated item since the 2026-07-14 confidential S-4 is an 2026-08-27 investor-conference release; no public S-4, no proxy, no vote date, so everything above the ~$10 trust reference is premium on an undated event, leaving a maturing narrative whose next test is the September conference window.
Kill line
A weekly close below $13 ends the June-to-August advance and leaves roughly $3 of premium over the ~$10 trust reference; the September conference window closing on 2026-09-29 with still no publicly filed S-4 and no announced shareholder-vote date is the confirming secondary condition.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for CCXI —
As of 19 September 2026, the latest FrontierPicks analysis for Churchill Capital Corp XI (CCXI): De-SPAC humanoid pure-play still bleeding premium: $17.07 (2026-08-14) → $14.57 (2026-08-21) → $13.40 (2026-09-04), RSI(14) down to 25.9. The only company-dated item since the 2026-07-14 confidential S-4 is an 2026-08-27 investor-conference release; no public S-4, no proxy, no vote date, so everything above the ~$10 trust reference is premium on an undated event, leaving a maturing narrative whose next test is the September conference window.
Kill line: A weekly close below $13 ends the June-to-August advance and leaves roughly $3 of premium over the ~$10 trust reference; the September conference window closing on 2026-09-29 with still no publicly filed S-4 and no announced shareholder-vote date is the confirming secondary condition.
Next dated event on file: — catalyst in 9d.
Current Thesis
Churchill Capital Corp XI’s humanoid-listing thesis has breached its published $13 weekly-close condition; reopening the case requires a price recovery and commercial evidence from Agility’s scheduled 2026-10-06 analyst day. The adjusted market close was $12.90 on Friday, 2026-09-18, below the threshold published on 2026-09-05. The original continuation case is therefore invalidated, rather than extended with a lower threshold.
The missing-registration premise also needs correction. Agility’s 2026-09-17 announcement confirms that a public Form S-4 merger registration statement has been filed. The same announcement schedules an analyst day for 2026-10-06; the calendar no longer ends with September’s conference appearances. Agility announcement, 2026-09-17.
As an inference about the published continuation case, the narrative is dead — the 2026-09-18 weekly close breached its stated condition despite renewed company activity. That classification concerns the price thesis: Agility’s investor page separately records the Digit 5 unveiling on 2026-09-15. Agility investor relations.
Bullish and bearish views on Churchill Capital Corp XI
The model's bull view on Churchill Capital Corp XI (CCXI), in brief: Product disclosure has advanced. Agility’s release index dates the Digit 5 unveiling to 2026-09-15. This supplies a concrete product milestone, although an unveiling alone does not establish customer revenue or manufacturing economics. Agility release index. Registration is no… The bear view: The published price condition failed. The 2026-09-18 adjusted close of $12.90 was below the $13 weekly threshold stated in the 2026-09-05 research note. New announcements do not reverse that recorded outcome. Attention has not repaired structure. InvestorPlace published… Both cases follow in full.
Bull Case
- Product disclosure has advanced. Agility’s release index dates the Digit 5 unveiling to 2026-09-15. This supplies a concrete product milestone, although an unveiling alone does not establish customer revenue or manufacturing economics. Agility release index.
- Registration is no longer merely confidential. The 2026-09-17 company announcement confirms a public registration statement. This removes the earlier filing-absence objection; the announcement does not specify a shareholder-vote date. Agility announcement.
- Momentum has improved on one measure. The supplied adjusted-bar observations show the 14-period relative strength index (RSI) at 38.9 on 2026-09-18, versus 25.9 on 2026-09-04. Those observations establish an indicator improvement, but the sample is too small to support a durable-reversal claim.
Bear Case
- The published price condition failed. The 2026-09-18 adjusted close of $12.90 was below the $13 weekly threshold stated in the 2026-09-05 research note. New announcements do not reverse that recorded outcome.
- Attention has not repaired structure. InvestorPlace published humanoid-robotics coverage featuring Digit 5 on 2026-09-17, while the supplied 2026-09-18 close remained below the published threshold. These observations establish coverage and price weakness, not a causal relationship between them. InvestorPlace, 2026-09-17.
- Financial confirmation remains incomplete here. Agility’s 2026-09-17 announcement describes planned discussion of its operating model but supplies no recognized-revenue, margin or cash-consumption figures. Those missing figures prevent this announcement from supporting an operating valuation. Agility announcement.
Setup & Price Structure
Measured on 2026-09-18, the adjusted close was $12.90, the three-month price change was positive 24.4%, and RSI was 38.9. A positive trailing return can coexist with a breached thesis condition; the dated close resolves the published $13 test.
No moving-average value, turnover series, short-interest figure or verified insider-sale record accompanies these observations. Distance above a rising moving average and positioning intensity therefore cannot be stated. The 2026-09-15 product announcement and 2026-09-17 retail-facing article establish renewed coverage, but the sample is too small to support a crowding claim. Agility release index, InvestorPlace.
Catalyst Calendar (next 30 days)
- 2026-09-29 — Evercore forum. Agility lists its robotics panel for 10:30–11:10 a.m. Eastern Time. This is a scheduled management appearance; the event listing contains no merger-vote deadline. Agility investor calendar.
- 2026-10-06 — Analyst and investor day. The 2026-09-17 announcement schedules discussion of manufacturing and operating economics. Disclosed commercial results would provide evidence beyond the product unveiling; a presentation without those results would leave that test unresolved. Agility announcement.
What Would Change Our Mind
The continuation structure broke when a weekly close below $13 occurred at $12.90 on 2026-09-18. That outcome remains part of the record even if subsequent prices recover.
A weekly close above $13, together with recognized revenue and deployment economics disclosed at the scheduled 2026-10-06 analyst day, would justify assessing a separate recovery thesis. Without both observations, the evidence would not establish that recovery case. The former secondary condition requiring a public registration statement has already been satisfied, according to Agility’s 2026-09-17 announcement. Agility announcement.
Correlation Notes
This remains a single-name merger setup. InvestorPlace’s 2026-09-17 article places Digit 5 within the broader humanoid-robotics discussion, establishing a thematic connection rather than a measured return correlation. No matched peer-return series is available here; the 2026-09-18 CCXI observations cannot establish sensitivity to another robotics company or to the wider technology market. InvestorPlace.
Notes
- Blank-check issuer: no operating results and no earnings date. The quote is trust value (~$10) plus deal premium until the merger closes.
- Ticker changes from CCXI to AGLT on close; the pre-close security is a Cayman SPAC Class A share, not Agility equity.
- Public shareholders may redeem at trust value at the vote regardless of market price; redemption is an alternative to selling.
- Units comprise one Class A share plus one-tenth of a warrant exercisable at $11.50; the sponsor note converts into units at $10.00.
- Agility financials are not yet public. The S-4 was submitted confidentially, so all revenue and order-book figures are company-supplied merger communications.
- Lockup commitments from employees, the Churchill family and initial investors were cited in the 2026-06-25 deal communication.
Related · shared themes
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.
DSGR
Distribution Solutions Group, Inc.
Distribution Solutions Group’s $35.00 cash acquisition remains a completion thesis, with the minority vote and closing settling the case. HSR clearance occurred on 2026-08-20; a daily close below $33.50 invalidates the price thesis.
ATKR
Atkore Inc.
Atkore's $95.00 cash-merger thesis now turns on the October 7 shareholder vote and remaining approvals after September 14 US antitrust clearance. Completion before a weekly close below $88 constitutes success; termination negates the case.